Navigation Links
AstraZeneca Offers Online Enrollment and Additional Improvements to Patient Assistance Program
Date:1/13/2010

WILMINGTON, Del., Jan. 13 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) announced today that enrollment and re-enrollment for two of its prescription savings programs is available online for the first time at www.azandme.com.

In addition, online self-service options are available for both programs, which enable health care providers, advocates and patients to order and monitor the shipping of refills and check the status of their enrollment online at www.azandme.com. AstraZeneca is the first pharmaceutical company to provide these self-service options directly to patients.

"We are using more tools to help patients get the medicines and information they need in an efficient and timely way," said Jennifer McGovern, AstraZeneca Director of Patient Assistance Programs. "We hope to be able to better serve patients and the people who support them by continually making program enhancements."

For over 30 years, AstraZeneca has offered patient assistance, because the company knows that medicines can only make a difference if patients can access them. Web-based improvements are another way that AstraZeneca is strengthening its commitment to patient health.

Program Details

To learn more about the program, get a list of available medicines, or to see if you qualify for an AZ&Me™ Prescription Savings program, please call  1-800-AZandMe (292-6363) or visit www.azandme.com. Assistance specialists are available Monday through Friday between 8 AM and 6 PM EST.

For those who prefer completing a hard-copy application, the AZ&Me™ Prescription Savings program for people without insurance and for people with Medicare Part D now also offers one streamlined application for both programs.  The application is available in English and Spanish at www.azandme.com or by calling 1-800-AZandMe (292-6363).

Prescription savings programs are available regardless of which medications doctors prescribe. To find out more about the more than 475 savings programs covering 2,500 medications, please visit www.pparx.org or call 1-888-4PPA-NOW (1-888-477-2669).

NOTES TO EDITORS:

About AstraZeneca

AstraZeneca is engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and in the supply of healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with global healthcare sales of $ 31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. In the United States, AstraZeneca is a $13.5 billion dollar healthcare business.

For more information about AstraZeneca in the US or our AZ&Me™ Prescription Savings programs, please visit: www.astrazeneca-us.com.

SOURCE AstraZeneca

RELATED LINKS
http://www.astrazeneca-us.com

'/>"/>

SOURCE AstraZeneca
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Novexel to be Acquired by AstraZeneca
2. AstraZeneca Medicare Part D Patient Assistance Program No Longer Requires Co-Pays
3. U.S. Court of Appeals Upholds AstraZeneca AWP Settlement
4. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
5. Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
6. Jubilant Enters Research Collaboration With AstraZeneca
7. AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
8. AstraZenecas Partner, MAP Pharmaceuticals, Announces Phase 3 Study of Unit Dose Budesonide in Children with Asthma Did Not Meet Primary Endpoints
9. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
10. AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Cognitive Dysfunction in Schizophrenia
11. AstraZeneca Receives Six Months Pediatric Exclusivity for CASODEX(R) (bicalutamide) from the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... Dublin - ... " Global Markets for Spectroscopy Equipment" report ... This report focuses on the global market of ... applications in various applications. The report deals with spectroscopy ... industries: pharmaceutical and biotechnology, food and beverage, and environmental ...
Breaking Medicine Technology:
(Date:6/26/2016)... Aliso Viejo, California (PRWEB) , ... June 26, 2016 , ... ... for Final Cut Pro X. , "Film editors can give their videos a whole ... artistically," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
Breaking Medicine News(10 mins):